Replies to post #349381 on NorthWest Biotherapeutics Inc (NWBO)

[learningcurve2020]

Obviously. lol. That’s all? You forgot about some of the incoming administration maybe even Biden himself??

16,000 + shareholders and they can’t apply enough pressure on leadership to publicly explain the endpoint changes and implications. Strange.

[extrooper]

Not according to the SEC .

[sukus]

Doctors are trained and be very careful on this type of information.

[MI Dendream]

I am not sure why I clicked back to read your post. It has been months since I have done so, but here is my opinion on your listing.

NWBO execs
. The stat team.
. Trial investigators
. The SAB and other outside experts
. 69 authors (and whoever they might use for help).
. The journal editors, clerks and peer review team
. Nice and the team of outside experts they include for review
. MHRA / FDA/ EMA and some Canadians.
. The team they contracted to put together BLA etc
. Cognate and Advent
. And all the various people around the primary's

Yes
A few
Yes
A very few - redundant to group 2
This seems like a big group, but the first and last are redundant and the middle is not informed
Not yet
A few high level people that know how to keep a secret - it is there job (statement generally applies to all affirmed people here)
Yes - team connotes a larger group than it would be
If so, execs only
No idea to whom you refer but NO

You suggest that people in this process are unethical. Generally speaking, this is not the case in medicine. Leaking destroys careers and is pursued by industry in courts if harmful. Peers are shunned. Wallstreet thinks we do not know who they wine and dine in order to leak... we do. It can be useful to leverage sometimes. Is is the American way.